XML 66 R55.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Subsequent Events (Details)
6 Months Ended
Aug. 01, 2024
USD ($)
shares
Jul. 26, 2024
USD ($)
shares
Jul. 22, 2024
USD ($)
shares
Jul. 12, 2024
USD ($)
Jul. 01, 2024
kg
Mar. 31, 2022
shares
Jun. 30, 2024
shares
Aug. 02, 2024
USD ($)
$ / shares
Jul. 24, 2024
USD ($)
May 12, 2024
shares
Feb. 29, 2024
$ / shares
Feb. 14, 2024
$ / shares
Dec. 31, 2023
shares
Subsequent Events [Line Items]                          
Number of common stock available for issuance                   416,667      
Price per share | $ / shares                       $ 4.5  
[1]             1,017,198           484,187
Converted shares           92,362 6,661            
Common Stock [Member]                          
Subsequent Events [Line Items]                          
Price per share | $ / shares                     $ 1    
Subsequent Event [Member]                          
Subsequent Events [Line Items]                          
Sale of stock 677,819                        
Proceeds for prospectus supplement | $ $ 1,994,583                        
Castanospermine of kilograms | kg         8.8                
Subsequent Event [Member] | At-the-Market Sales Agreement [Member]                          
Subsequent Events [Line Items]                          
Issuance of sale | $       $ 15,000,000                  
Maximum aggregate offering price | $   $ 2,190,416 $ 1,774,640 1,253,603       $ 2,295,192 $ 1,890,705        
Subsequent Event [Member] | Knight Therapeutics, Inc. [Member]                          
Subsequent Events [Line Items]                          
Converted shares   33,334 40,000                    
Subsequent Event [Member] | WallachBeth Capital LLC [Member] | At-the-Market Sales Agreement [Member]                          
Subsequent Events [Line Items]                          
Maximum aggregate offering price | $       $ 15,000,000                  
Subsequent Event [Member] | Subsequent Event [Member]                          
Subsequent Events [Line Items]                          
Common stock meet or exceed per share | $ / shares               $ 1          
Common Stock [Member] | Maximum [Member]                          
Subsequent Events [Line Items]                          
            21,219,937            
Common Stock [Member] | Minimum [Member]                          
Subsequent Events [Line Items]                          
            1,768,337            
Series A Preferred Stock [Member]                          
Subsequent Events [Line Items]                          
Converted shares           80,965              
Series A Preferred Stock [Member] | Subsequent Event [Member] | Knight Therapeutics, Inc. [Member]                          
Subsequent Events [Line Items]                          
Converted shares   1,032 1,291                    
[1] Periods presented have been adjusted to reflect the 1:12 reverse stock split on August 12, 2024. See Note 12 - Subsequent Events for more information.